Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (361-370 of 560) with videos related to

Pageof 56
Sort By:
Cancer Medicine|December 2, 2020
Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancerSamilia Obeng-Gyasi, Anne O'Neill, Fengmin Zhao, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2010
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancerAllyson J Ocean, Paul Christos, Joseph A Sparano, et al.
Thoracic Cancer|October 1, 2019
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminomaRaimondo Di Liello, Francesca Sparano, Maria Lucia Iacovino, et al.
The Lancet. Oncology|June 2, 2012
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpointsDebora Fumagalli, Philippe L Bedard, Zeina Nahleh, et al.
Nature Cancer|October 18, 2021
Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapyAstha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancerKathy D Miller, Thomas J Saphner, David M Waterhouse, et al.
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
Clinical Breast Cancer|July 7, 2011
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancerAyca Gucalp, Joseph A Sparano, James Caravelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Critical Reviews in Oncology/Hematology|April 6, 2024
Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic reviewEvelyne Roets, Winette van der Graaf, Bauke H G van Riet, et al.
Pageof 56

Showing results (361-370 of 560) with videos related to

Sort By:
Pageof 56
Cancer Medicine|December 2, 2020
Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancerSamilia Obeng-Gyasi, Anne O'Neill, Fengmin Zhao, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2010
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancerAllyson J Ocean, Paul Christos, Joseph A Sparano, et al.
Thoracic Cancer|October 1, 2019
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminomaRaimondo Di Liello, Francesca Sparano, Maria Lucia Iacovino, et al.
The Lancet. Oncology|June 2, 2012
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpointsDebora Fumagalli, Philippe L Bedard, Zeina Nahleh, et al.
Nature Cancer|October 18, 2021
Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapyAstha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancerKathy D Miller, Thomas J Saphner, David M Waterhouse, et al.
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
Clinical Breast Cancer|July 7, 2011
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancerAyca Gucalp, Joseph A Sparano, James Caravelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Critical Reviews in Oncology/Hematology|April 6, 2024
Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic reviewEvelyne Roets, Winette van der Graaf, Bauke H G van Riet, et al.
Pageof 56